Navigation Links
New: Longevinex(R) First to Introduce Micronized Resveratrol Matrix - Now Stabilized by Microencapsulation
Date:4/22/2008

SAN DIMAS, Calif., April 22 /PRNewswire/ -- To enhance absorption, the Longevinex(R) matrix of nutraceuticals now features micron-sized trans-resveratrol, microencapsulated in an envelope of all natural plant dextrins and starches to preserve resveratrol in its trans-resveratrol form from degradation by light, heat and oxygen. (Refs 1, 2)

(Photo: http://www.newscom.com/cgi-bin/prnh/20080422/LATU004 )

The newly formulated Longevinex resveratrol matrix withstands direct exposure to solar ultraviolet radiation and heat in independent laboratory tests, says Bill Sardi, spokesperson for Longevinex. (To learn more about microencapsulation online, visit: http://en.wikipedia.org/wiki/Micro-encapsulation )

Microencapsulation protects resveratrol from environmental factors before it is encapsulated into a larger oral capsule. Microencapsulation also facilitates slow release and better absorption.

The ingredients in Longevinex(R) capsules are newly formulated to provide rice bran ferulate, and natural vitamin D3.

The ingredients in Longevinex(R) work additively and synergistically, says Sardi. Vitamin D3 works to breakdown rice bran IP6, a whole-grain factor also provided in Longevinex, into IP3, which is its primary active form. Quercetin allows more resveratrol to pass through the liver before it is metabolized, improving immediate bioavailability of resveratrol.

A drawback of most resveratrol supplements is their emodin content. Small amounts of emodin can induce loose stool in sensitive individuals. Resveratrol in Longevinex(R) is a purified form that is virtually emodin-free.

The newly formulated Longevinex(R) matrix is produced in a vege-capsule, to meet requirements of vegetarians.

Longevinex(R) provides a unique array of mineral chelators (patent appli
'/>"/>

SOURCE Longevinex
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Lincare Holdings Inc. Announces First Quarter 2008 Financial Results
2. Darwin to Announce First Quarter 2008 Financial Results
3. Omnicell Announces First Quarter 2008 Results
4. ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2008 Financial Results
5. Old Orchard Introduces First Multi-Serve Vitamin Water, Sweetened with Agave Nectar and Real Fruit Juice
6. Survey offers first-ever look at treatment practices for nonepileptic seizures
7. HMS Holdings Corp. Hosts First Quarter 2008 Financial Teleconference and Presentation
8. Sorrento(R) Cheese Launches First Omega-3 Cheese on the Market
9. Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008
10. QLT announces first quarter 2008 Visudyne(R) sales
11. Echo Therapeutics and Cato BioVentures Sign Right of First Offer Agreement for Dermatology Products and Transdermal Drug Delivery Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...reworks hazards , , FRIDAY, July 3 (Heal...use almost 10,000 injuries every year in the Unite...keep you and others safe while enjoying the key su...lth Inc. Corporation, which runs several Georgia-b...reworks safety: , Obey all local laws regarding ...
(Date:7/3/2009)...ewswire-Asia/ -- Sundia MediTech, a leading,integ...ng company in Shanghai,China announced today tha...esident of Chemistry Services. , Prior to j...iences, a drug,discovery and development company ...ntist to Senior Director of Medicinal Chemistry of...
(Date:7/3/2009)...ew urine drug test kit called DrugConfirm™ ,... that want a fast and accurate instant drug test. ...the cup has a sleek, innovative design and incorpo...very competitively priced compared to the other ur...the market , San Diego (V...
(Date:7/3/2009)...erseAges.com launches new content to include infor... and how to best deal with these health issues. ,...y 3, 2009 -- ReverseAges.com has recently launched...ngers of common health issues such as high blood p...y of factors, and the new content on ReverseAges.c...
Breaking Medicine News(10 mins):Health News:Put Safety First on the 4th 2Health News:Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry 2Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 2Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 3
...cent study shows that larger portions lead to grea...food, greater the amount that is eaten. Researcher...e differed depending on who determined the amount/...carried out with 50 men and women who were served ...
...glow that fireflies are famous for, are due to a g...lecule is now helping illuminate the effectiveness...new drugs for various diseases like AIDS,// Alzhei...carried out by researchers of the University of Mi...
...le and old age people are now increasingly taking ...rammes paint a rosy picture of beautiful gardens. ...health benefits, researchers now suggest that enth... no idea of how to lift properly and do not have a...
...foundation of diabetics care is the regular monito...any patients do not adhere to this routine because...multiple blood samples to be taken by puncturing//...rom University of Texas have discovered a new non-...
Other Medicine News:
(Date:6/29/2009)..., SOUTHAMPTON, England, June 29 /PRNewswire/ ...l company developing novel, small molecule drugs,...unces positive results from,a Phase IIa clinical ...r,nocturia. The trial showed that oral VA106483 w...ained anti-diuretic effect in patients, as determi...
(Date:6/26/2009)..., DEERFIELD, Ill., June 26, and OSAKA, Japan, Jun...ompany Limited ("Takeda") today announced that Tak..., a wholly owned United States (U.S.) subsidiary r... letter from the U.S. Food and Drug Administration...n (NDA) for alogliptin, a selective dipeptidyl pep...
(Date:6/26/2009)..., Positive Opinion Recommends Approval of New Ant...el SmartJect(TM) Autoinjector , , HORSHAM, Pa. ...l/ -- Centocor Ortho Biotech Inc. and Schering-Plo...t the Committee for Medicinal Products for Human U...adopted a positive opinion recommending the approv...
(Date:6/25/2009)..., Company Also Receives Patent Covering ARIKACE f...ions , , MONMOUTH JUNCTION, N.J., June 25 /PRNe... Inc., the nonprofit affiliate of the Cystic Fibro...to Transave Inc., for the continued development of...an antibiotic that aims to treat Pseudomonas lun...
Breaking Medicine Technology:Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 2Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 3Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 4Genes influence effectiveness of weight loss drug 26917 1Genes influence effectiveness of weight loss drug 26917 2Genes influence effectiveness of weight loss drug 26917 3Hay fever may be best treated with self adjusted dosing 26915 1Hay fever may be best treated with self adjusted dosing 26915 2Asian white couples face distinct pregnancy risks Stanford Packard 26913 1Asian white couples face distinct pregnancy risks Stanford Packard 26913 2Asian white couples face distinct pregnancy risks Stanford Packard 26913 3Cylex 28TM 29 Receives ISO 13485 3A2003 and 9001 3A2000 Quality Certifications 8004 1Cylex 28TM 29 Receives ISO 13485 3A2003 and 9001 3A2000 Quality Certifications 8004 2
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and
This blanket gently surrounds the child with temperature-controlled air. Use one or both of the enclosed clear plastic drapes to keep warmed air near the skin.
2-ply material consisting of polyethylene film inner layer and non-woven outer layers.
This unique blanket is designed to be used for many surgical procedures, including but not limited to: laminectomies, spinal procedures, abdominal procedures, and transplants.
Medicine Products: